34
Participants
Start Date
April 2, 2018
Primary Completion Date
October 29, 2020
Study Completion Date
April 2, 2021
Dermacell
Subject will receive treatment for one non-healing deep diabetic foot ulcer using one Dermacell acellular matrix. Subject will be followed up to 16 weeks post treatment, or until wound has closed, whichever comes first.
Integra
Subject will receive treatment for one non-healing deep diabetic foot ulcer using one Integra bilayer cross-linked matrix. Subject will be followed up to 16 weeks post treatment, or until wound has closed, whichever comes first.
Baylor College of Medicine, Houston
Collaborators (1)
LifeNet Health
INDUSTRY
Baylor College of Medicine
OTHER